Prime Minister Justin Trudeau today announced another contract to purchase a very promising COVID-19 vaccine, currently under development, which is part of a plan to secure millions of doses of vaccine to vaccinate Canadians from the new coronavirus. Johnson and Johnson appears to have a solid production base and the company has reiterated its amazing goal of producing more than 1 billion doses of its vaccine by the end of 2021. On September 3, Sanofi and GlaxoSmithKline said their vaccine would begin phase 1/2 studies that they will test on 440 people. The hope is that the vaccine will be ready for the third and final phase of the trials by the end of the year and that it will be allowed to be used in the first half of 2021. On Tuesday, Prime Minister Justin Trudeau tried to temper Canadians` expectations about when and how to implement a possible vaccine or vaccine to immunize against the new coronavirus, acknowledging that Canada had a “disadvantage” because Canada “no longer had domestic production capacity” to make our own and defers to other nations. The head of the vaccination group at The University of Oxford called it the “vaccine for the world.” This is partly because it is a small cost — about $3 per dose, one-fifth of Pfizer and Moderna vaccines — and because it can be stored at the temperature of a common refrigerator. These are part of the 40 million guaranteed doses and up to a total of 56 million doses guaranteed by Canada through its existing agreement with Moderna. As with all COVID 19 vaccines, the Moderna vaccine must be approved by Health Canada before being administered to Canadians. “The best way to end this pandemic and keep Canadians healthy is a safe and effective vaccine. By investing in several vaccine candidates and ensuring that one is distributed from coast to coast, we are taking the necessary steps to get Canadians on the road to recovery from COVID-19. At the same time, the National Advisory Committee on Immunization, an external advisory group of immunization and health experts, will provide federal, provincial and territorial governments with guidance for safe and effective application of vaccines for Canadians. The Canadian government has submitted 6 standing offers for weekly dry ice delivery, as required, to support the storage and transportation of COVID 19 vaccines. “The way we do this is to bet on several horses at the same time to make sure that if one or more of these horses cross the finish line, we will have access to these vaccines,” she said. The Canadian government protects the health and safety of all Canadians, while ensuring a safe and sustainable economic recovery.
These include measures to ensure that Canadians have access to future vaccines and treatments and that the health care system has the tools they need to make it available effectively. The Canadian government purchased 422 freezers to store COVID 19 vaccines. This is it. A first batch of 30,000 doses arrived on December 14, with long-term caregivers and workers among the first to receive the vaccine. Prime Minister Justin Trudeau announced earlier this month that Canada is expected to provide 249,000 doses by the end of the year. “Given the growing number of COVID patients across the EU, a safe and effective vaccine is more important than ever to end the pandemic,” Stella Kyriakides, the union`s commissioner for health and food safety, said on Tuesday. Faced with vaccines at hand against the new coronavirus, countries around the world are rushing to access doses they hope will help end a deadly pandemic that has claimed the lives of more than 1.3 million people to date. Drug manufacturer AstraZeneca has partnered with Oxford University for the vaccine, which is currently in Phase 3, for large-scale efficacy testing.
The company has begun publishing interim analyses of its clinical studies in the Uk and Brazil. On October 12, 2020, Moderna submitted an application for review of its COVID-19 vaccine candidate, in accordance with Health Canada`s interim arrangement.